高级检索+

谷氨酰胺强化肠外营养对家兔肠炎模型辅助治疗作用的研究

Study of the adjuvant therapy effect of glutamine-enhanced parenteral nutrition on rabbit enteritis model

  • 摘要: 为了研究谷氨酰胺强化肠外营养对肠炎类疾病的作用,试验将6只家兔随机分为试验组和对照组,分别使用1%乙酸和纯化水灌肠的方法建立肠炎模型,通过观察临床症状和病理学变化评估模型建立情况,在使用常规对症抗菌药物治疗的基础上按照加入药物的不同将建立的24只肠炎模型家兔随机分为Ⅰ组(生理盐水)、Ⅱ组(谷氨酰胺)、Ⅲ组(全价营养液)和Ⅳ组(谷氨酰胺和全价营养液),每组6只。在治疗前和治疗5 d后观察家兔临床症状,采用联苯胺法检测粪便潜血情况,评估疾病活动指数(DAI);采集血液并通过相应仪器检测血常规和血液生化指标;以双抗体一步夹心法酶联免疫吸附试验检测D-乳酸(D-LA)含量。结果表明:与对照组相比,试验组家兔临床症状和病理变化明显,成功建立了家兔肠炎模型。与治疗前比较,治疗后Ⅳ组DAI下降最明显,显著低于其他组(P<0.05)。治疗后Ⅳ组白细胞数量显著高于其他组(P<0.05),Ⅲ组、Ⅳ组红细胞数量、血红蛋白含量显著高于Ⅰ组、Ⅱ组(P<0.05);与治疗前比较,各组血小板数量上升且治疗后Ⅲ组、Ⅳ组显著低于Ⅰ组、Ⅱ组(P<0.05);治疗前后各组丙氨酰氨基转移酶、天门冬氨酸氨基转移酶活性差异不显著(P>0.05);治疗后Ⅰ组白蛋白、总蛋白含量显著低于其他组(P<0.05),Ⅲ组、Ⅳ组尿素氮、肌酐、三酰甘油、葡萄糖含量显著高于Ⅰ组、Ⅱ组(P<0.05),Ⅳ组D-LA含量显著低于其他组(P<0.05)。说明谷氨酰胺强化的肠外营养具有减轻临床症状、保证机体营养需求、调节免疫功能、修复肠黏膜屏障等作用,可用于辅助治疗肠炎类疾病。

     

    Abstract: In order to study the effect of glutamine-enhanced parenteral nutrition on enteritis diseases, the experiment divided 6 rabbits into experimental group and control group at random, using 1% acetic acid and purified water enema respectively to establish the enteritis model. By observing the clinical symptoms and pathological changes to evaluate the establishment of the model, on the basis of the use of conventional symptomatic antimicrobial treatment, according to the different drugs added, the 24 established enteritis model rabbits were randomly divided into group Ⅰ(normal saline),group Ⅱ(glutamine),group Ⅲ(full price nutrient solution),and group Ⅳ(glutamine and full price nutrient solution); with 6 rabbits in each group. The clinical symptoms of rabbits were observed before treatment and 5 days after treatment; benzidine method was used to detect fecal occult blood; and disease activity index(DAI) was evaluated. Blood was collected for the measurement of blood routine and blood biochemical indexes with corresponding instruments. D-lactic acid(D-LA) content was detected by double-antibody one-step sandwich enzyme-linked immunosorbent assay(ELISA). The results showed that compared with the control group, the experimental group had obvious clinical symptoms and pathological changes, and the rabbit enteritis model was successfully established. Compared with before treatment, DAI in group Ⅳ decreased significantly, which was lower than that in other groups(P<0.05). After treatment, the number of WBC in group Ⅳ was higher than that of other groups(P<0.05);the number of RBC and HGB in group Ⅲ and group Ⅳ were higher than those in groups Ⅰ and Ⅱ(P<0.05). Compared with before treatment, the number of PLT in each group increased after treatment, and group Ⅲ and group Ⅳ were significantly lower than group Ⅰ and group Ⅱ(P<0.05). The AST and ALT activities of each group were not significantly different before and after treatment(P>0.05). After treatment, the contents of ALB and TP in group Ⅰ were significantly lower than others Group(P<0.05);after treatment, the CRE and BUN contents of group Ⅲ and group Ⅳ were significantly higher than those of group Ⅰ and group Ⅱ(P<0.05),and the contents of BUN, CRE, TRIG and GLU of group Ⅲ and group Ⅳ were significantly higher than those of group Ⅰ and group Ⅱ(P<0.05). After treatment, the D-LA content of group Ⅳ was lower than that of other groups(P<0.05). The results suggested that glutamine-enhanced parenteral nutrition has the functions of reducing clinical symptoms, providing the body′s nutritional requirements, regulating immune function, and repairing the intestinal mucosal barrier, and could be used as an auxiliary treatment for enteritis diseases.

     

/

返回文章
返回